Dumont Sylvain, Bloch Vanessa, Lillo-Lelouet Agnès, Le Beller Christine, Geoffroy Pierre A, Veyrier Marc
Service Pharmacie, AP-HP, GHU Paris Nord, DMU PRISME, Hôpital Bichat-Claude Bernard, Paris, France.
Service Pharmacie, AP-HP, GHU Paris Nord, DMU PRISME, Hôpital Larboisière-Fernand Widal, Paris, France.
J Sleep Res. 2025 Apr;34(2):e14306. doi: 10.1111/jsr.14306. Epub 2024 Sep 7.
Parasomnias and sleep-related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for reporting systematic reviews, we searched PubMed databases between January 2020 and June 2023. The searches retrieved 937 records, of which 174 publications were selected for full-text screening and 73 drugs were identified. The most common drug-induced parasomnias were nightmares and rapid eye movement (REM) sleep behaviour disorders and sleepwalking. In terms of drug-induced SRMD, restless legs syndrome, periodic limb movement disorders (PLMD), and sleep-related bruxism were most frequent. Medications that inhibit noradrenergic, serotonergic, or orexin transmission could induce REM sleep (e.g., nightmares). Regarding sleepwalking, dysregulation of serotoninergic neurone activity is implicated. Antipsychotics are mentioned, as well as medications involved in the gamma-aminobutyric acid (GABA) pathway. A mechanism of desensitisation-autoregulation of GABA receptors on serotoninergic neurones is a hypothesis. SRMD and PLMD could involve medications disrupting the dopamine pathway (e.g., antipsychotics or opioids). Opioids would act on mu receptors and increase dopamine release. The role of adenosine and iron is also hypothesised. Regarding bruxism, the hypotheses raised involve dysregulation of mesocortical pathway or a downregulation of nigrostriatal pathway, related to medications involving dopamine or serotonin. Parasomnias are rarely identified in drug product labels, likely due to the recent classification of their diagnoses. An analysis of pharmacovigilance data could be valuable to supplement existing literature data.
异态睡眠和睡眠相关运动障碍(SRMD)是睡眠障碍的主要原因,且可能由药物诱发。本研究的目的是对文献进行系统综述,以考察药物使用与异态睡眠及SRMD发生之间的关联。按照系统综述和Meta分析的首选报告项目(PRISMA)指南来报告系统综述,我们检索了2020年1月至2023年6月期间的PubMed数据库。检索共获得937条记录,其中174篇出版物被选作全文筛选,共识别出73种药物。最常见的药物诱发异态睡眠是噩梦、快速眼动(REM)睡眠行为障碍和梦游。在药物诱发的SRMD方面,不宁腿综合征、周期性肢体运动障碍(PLMD)和睡眠相关磨牙症最为常见。抑制去甲肾上腺素能、血清素能或食欲素传递的药物可诱发REM睡眠(如噩梦)。关于梦游,血清素能神经元活动失调与之有关。文中提到了抗精神病药物以及参与γ-氨基丁酸(GABA)途径的药物。血清素能神经元上GABA受体脱敏-自动调节的机制是一种假说。SRMD和PLMD可能涉及破坏多巴胺途径的药物(如抗精神病药物或阿片类药物)。阿片类药物作用于μ受体并增加多巴胺释放。腺苷和铁的作用也被提出假说。关于磨牙症,提出的假说涉及中皮质通路失调或黑质纹状体通路下调,这与涉及多巴胺或血清素的药物有关。异态睡眠在药品标签中很少被识别,可能是由于其诊断的近期分类。药物警戒数据分析对于补充现有文献数据可能很有价值。